Veliparib for induction treatment of previously untreated advanced ovarian, fallopian tube and primary peritoneal cancer in combination with carboplatin and paclitaxel, followed by veliparib maintenance treatment as a monotherapy [ID1561]

  • Discontinued
  • GID-TA10442
Following on from advice received from the company the timelines for this appraisal are to be confirmed and further information regarding the scheduling of this appraisal will be available in due course.